![Eli Aharoni](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eli Aharoni
Technik-/Wissenschafts-/F&E-Leiter bei SAMSARA VISION, INC.
Aktive Positionen von Eli Aharoni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAMSARA VISION, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
Karriereverlauf von Eli Aharoni
Ehemalige bekannte Positionen von Eli Aharoni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACCELERON PHARMA INC. | Finanzdirektor/CFO | 01.04.2008 | - |
Ausbildung von Eli Aharoni
Technion-Israel Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Israel | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Samsara Vision, Inc.
![]() Samsara Vision, Inc. Medical SpecialtiesHealth Technology Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ. | Health Technology |
Acceleron Pharma, Inc.
![]() Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Börse
- Insiders
- Eli Aharoni
- Erfahrung